Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 10,000 shares at $0.55 ($6K) on 2017-08-24, disclosed to the SEC on 2017-08-24.
Open-market purchase of $6k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.55 | 4,361 | $2K | 43.6% |
| 2 | $0.55 | 4,900 | $3K | 48.9% |
| 3 | $0.56 | 739 | $414 | 7.5% |
| Total | $0.55 avg | 10,000 | $6K | 100% |
| Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |
| RXII | BUY | 2017-02-21 | $7K | — | Filing → |